This program is initiated, funded, and developed by Biogen.
Advertisement
Articles by This program is initiated, funded, and developed by Biogen.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
AAO 2025: Ashkan Abbey on the outcomes of EYP-1901 for AMD and DME
2
Leadership in action during the 2025 AAO named lectures
3
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
4
Empowerment through education: Q&A with Inder Paul Singh, MD
5
